323U66 SR

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 323U66 SR, covering 2013-05-06 to 2019-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study Of 323U66 SR In Major Depressive Disorder [Phase 2]